Fanapt (iloperidone), an antipsychotic therapy, is indicated in US for the acute treatment of schizophrenia in adults, set for US launch in early 2010 Addition of Fanapt will strengthen Novartis psychiatry portfolio and build on history in schizophrenia…
Biopharmaceuticals, Licensing
Novartis, Novartis Pharmaceutical AG, Vanda Pharmaceuticals, Fanapt, iloperidone

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia”
Leave a Comment